Fenel is a seasoned executive in the Life Sciences Sector. He was most recently the COO of Cell Signaling Technology, Inc., a privately held Life Sciences company, where he grew the business at a CAGR of 15% over a period of 12 years and provided leadership in the transformation of the company to a global operation. Prior to that, he was the COO of Interleukin Genetics, Inc., a formerly NASDAQ-listed diagnostic company, for 5 years. Prior to Interleukin, he was CFO at LifeCell and Genome Therapeutics, both formerly NASDAQ-listed companies, for a combined period of twelve years. During his professional career, Fenel has scaled up operations, expanded businesses both organically and through strategic partnerships and completed a number of public and private financing transactions. His leadership experience spans various sizes of companies from start-ups to multinationals. Fenel has an MBA and a BA in Business and Finance.